Karpefors, M.
AstraZeneca (Sweden)
2 papers on CoChatORCID 0000-0003-3136-9882
Most cited papers
- Verified
Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS: GI-specific anxiety in IBS
Jerndal, P., Ringström, G., Agerforz, P., Karpefors, M., Akkermans, L. M., Bayati, A., & Simrén, M. (2010) · Neurogastroenterology & Motility
Gastrointestinal motility and disordersPsychosomatic Disorders and Their Treatments
Cited by 192
- Verified
Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes
Gummesson, A., Nyman, E., Knutsson, M., & Karpefors, M. (2017) · Diabetes Obesity and Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 162
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free